Zoetis, a New Jersey-based producer of medication for pets and livestock, sued Boehringer Ingelheim Vetmedica GmbH Friday in New York Southern District Court for alleged breach of contract. The lawsuit, filed by Panitch Schwarze Belisario & Nadel LLP, accuses the defendant of failing to make royalty payments of more than $31 million under a patent licensing agreement for certain animal vaccines. Counsel have not yet appeared for the defendants. The case is 1:21-cv-08319, Zoetis, Inc. v. Boehringer Ingelheim Vetmedica, GmbH.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
